Pharmacovigilance data protection: how we guarantee maximum security

Pharmacovigilance data protection is a fundamental element for pharmaceutical companies. To guarantee security for users of SafetyDrugs, the safety database, we have relied on Oracle data centres for years.

Where is the data hosted? This is one of the questions we are most often asked by our interlocutors during the product presentation phase. We understand that pharmacovigilance data protection is a crucial element for pharmaceutical companies and this is why we are committed to ensuring data security for our clients. To do this, we relied on the technological partner Oracle: all the data entered into SafetyDrugs is hosted inside a data center whose security standards are among the highest in the world. Here are some of its features.

Oracle data centre requirements comply with Tier III standards, data security certifications such as PCI DSS, HIPAA, SOC 1/SOC 2, with general security guidelines ISO/IEC 27002, with international standard ISO/IEC 27001 and with Information Security Management Systems standards ISO/IEC 27701, 27017 and 27018.

During transmission, data is protected by an advanced encryption system* that protects against violations. It is a procedure that is added to various implementations made to the database with the new release: by accessing the database without the necessary decryption keys, it will be impossible for anyone to read the data. The database automatically handles encryption and decryption through the Transparent Data Encryption (TDE) function.
* TLS 1.2 enabled connection negotiated for encryption of at least 128 bits or higher and private key used for encrypted key generation of at least 2048 bits.

In the event of a catastrophic event or cyber-attack, the Oracle Recovery Manager system procedures offer rapid recovery times and certainty about the integrity of the database. Unlike what happens in synchronous copy processes, Oracle limits the risk of data compromise by performing deferred copying on a secondary site with stand-by machines.

The Oracle brand represents a firm point in the panorama of technology operators. It is a reality whose 430 thousand customers, present in 175 countries around the world, every day safely ride the business opportunities offered by IT tools.

The choice of the Oracle data center is the pinnacle of the partnership between Max Application, the developer of SafetyDrugs, and the American group, which began in the 1990s with the adoption of their database. Today the technology of our IT services is based on Oracle Cloud: the infrastructure (IaaS), the platform (PaaS) and the software (SaaS), including SafetyDrugs. The complete integration of the three levels of the entire technological structure in a single environment increases the performance of the system and the operational efficiency of the user.

Our decision to choose the Oracle data center to host SafetyDrugs data reflects our ongoing commitment to protecting pharmacovigilance data. High protection, compliance with quality standards and rapid response to extraordinary events confirm the solidity of our decision. With SafetyDrugs, we guarantee pharmacovigilance managers a high-performance and safe product.